Cristina Martínez-Toledo

PhD Student at Hospital Universitario Puerta de Hierro | Lung Cancer & Bioinformatics 🫁💻

[Belén Sierra @sierra_belen]

Proud to share preliminary results on the potential of the BCR repertoire as a survival biomarker, presented at #WCLC2026 in Seoul 🇰🇷

Why B cells? Because B cells have a lot to say! 🧬

Grateful to our patients, investigators, lab team & @gecp_org . Let’s keep exploring!

[Alberto Cruz-Bermúdez @CruzAPhD]

Proud to present our work at @IASLC #WCLC26 in Seoul! 🇰🇷

“Not All Residual Tumors Are Created Equal: Perioperative Chemoimmunotherapy Differentially Shapes Tumor Microenvironment” 🧬🫁

Using ST from @10xGenomics our study explores different resistance mechanisms.
@gecp_org 👏

[Juan Manuel Gutierrez-Escobedo @JuanManuel_GE]

Today, I had the great opportunity to present our work, “B Cell Density in Mature Tlss Is Associated With Pathological Complete Response After Neoadjuvant Chemoimmunotherapy,” at #WCLC26 in Seoul, Korea 🇰🇷

Many thanks to @gecp_org and @IASLC for the opportunity and support!

[Grupo Español de Cáncer de Pulmón @gecp_org]

🔬 @Serna_Blasco, investigador del @HospiPtaHierro de Madrid, presenta en #WCLC2026 un nuevo póster del #GECP:

➡️ Microbiome Functional Signatures as Potential Biomarkers and Mechanistic Modulators of Response to Neoadjuvant Therapy in NSCLC

⭕El estudio analiza diferentes firmas funcionales del microbioma y su potencial como biomarcadores

#WCLC26 #NSCLC

[Grupo Español de Cáncer de Pulmón @gecp_org]

🔬 Alejandro Rodríguez-Festa, researcher at the Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, presents a new #GECP poster at #WCLC2026:

➡️ Gut Microbiome Taxa Associated With Response to Chemoimmunotherapy in NSCLC: A Multi-Method Differential Abundance Analysis

#WCLC26

[Grupo Español de Cáncer de Pulmón @gecp_org]

🔬 Cristina Martínez-Toledo @HospiPtaHierro presenta en #WCLC2026 el póster:

➡️ Top 1% Baseline Tissue TCR Clones Presence in Blood Associate with Complete Responses After Perioperative Chemoimmunotherapy

Nuevos datos sobre la asociación entre clones TCR y respuesta completa tras quimioinmunoterapia perioperatoria.

[Grupo Español de Cáncer de Pulmón @gecp_org]

🔬 @sierra_belen @HospiPtaHierro presents a new #GECP poster at #WCLC2026:

➡️ Tumor BCR Repertoire Metrics Outperform PD-L1 and TMB as Survival Biomarkers in NSCLC After Adjuvant Chemoimmunotherapy

The study explores tumor BCR repertoire metrics as potential survival biomarkers after adjuvant chemoimmunotherapy.

[Alberto Cruz-Bermúdez @CruzAPhD]

Great results from the @gecp_org DUMAS trial presented by @MARIANOPROVENCI at #WCLC26 in Seoul!

The first prospective trial evaluating perioperative ChIO in patients with Pancoast tumours, showing encouraging survival and a 58% pCR rate, with 86% undergoing surgery 👏🫁🔬

[Grupo Español de Cáncer de Pulmón @gecp_org]

@AVanessaOspinaS miembro del GECP @HospiPtaHierro presenta en #WCLC2026 nuevos resultados de NADIM II y REAL-NADIM.
➡️ Mini oral - Role of PET/CT in the Neoadjuvant Chemoimmunotherapy Approach for Resectable NSCLC: Results from the NADIM II and REAL-NADIM Trials
👉El trabajo profundiza en el papel del PET/CT en el abordaje neoadyuvante del CPNM resecable.

[Grupo Español de Cáncer de Pulmón @gecp_org]

🗣️ @MARIANOPROVENCI, President of the #GECP, presents the results of the DUMAS trial as a Mini Oral at #WCLC2026.

➡️ First prospective trial evaluating perioperative chemoimmunotherapy in Pancoast tumors.

📊 58% pathological complete response
🔬 86% of patients underwent surgery
📈 Encouraging survival outcomes
#WCLC26 #LungCancer

[Grupo Español de Cáncer de Pulmón @gecp_org]

⭕🗣️ @angelesgilg @HospiPtaHierro presenta en #WCLC2026 nuevos resultados del GECP sobre estructuras linfoides terciarias tras quimioinmunoterapia perioperatoria.
➡️ Mini oral - Tertiary Lymphoid Structures After Perioperative Chemoimmunotherapy Are Associated With Reduced Disease Progression in NSCLC
➡️El trabajo muestra su asociación con una menor progresión de la enfermedad.

[Ángeles Gil-González @angelesgilg]

Presenting at #WCLC26 today during the MO05 session was an absolute honor and an unforgettable experience! Huge thank you to @IASLC for this incredible opportunity, and to everyone who came to support and engage with our work. On cloud nine! 🫁✨

[Cristina Martínez-Toledo @CMartinezToledo]

Here you can check the key results presented today! 🫁

A huge thank you to the patients, all the collaborators and lab members who made this work possible! ✨

@CruzAPhD @MARIANOPROVENCI @sierra_belen @angelesgilg @mmolinalejandre @JuanManuel_GE

[Cristina Martínez-Toledo @CMartinezToledo]

Grateful once again to @IASLC for the opportunity to present our work on TCR clone dynamics during perioperative immunotherapy. 🫁🔬

So happy to be here, share our results and keep learning from such an inspiring scientific community!

#WCLC26 @gecp_org

[IASLC @IASLC]

@CMartinezToledo @gecp_org Thank you for being part of #WCLC26 and sharing your work with the global community!

[Grupo Español de Cáncer de Pulmón @gecp_org]

🔬 Marta Martínez-Cutillas del @HospiPtaHierro presenta en #WCLC2026 el póster:

➡️ Causes and Patterns of Mortality After Surgery in Patients with Non-Small Cell Lung Cancer: A Retrospective Study

#GECP #WCLC26 #LungCancer #NSCLC

[Grupo Español de Cáncer de Pulmón @gecp_org]

Bartomeu Massutí, secretario del #GECP, presenta en #WCLC2026 el póster:

➡️ Persistent N2 After Neoadjuvant Chemoimmunotherapy in Non-Small Cell Lung Cancer: Insights from Three Prospective Cohorts

Nuevos datos sobre N2 persistente tras quimioinmunoterapia neoadyuvante.

#GECP #WCLC26 #NSCLC

[Grupo Español de Cáncer de Pulmón @gecp_org]

🗣️ Ana San Martín Doblado @HospiPtaHierro presents new GECP results on the gut microbiome in lung cancer at #WCLC2026.
➡️ Minioral - Association of Gut Microbiome Diversity With Survival and Immune-Related Toxicity in Locally Advanced NSCLC
➡️The studyexplores its association with survival and immune-related toxicity in locally advanced NSCLC.

[Ángeles Gil-González @angelesgilg]

I’m an honored recipient of the Early Career Award at the 2026 WCLC. Thank you so! @IASLC

[Marta Molina Alejandre @mmolinalejandre]

Huge congratulations to my colleague @angelesgilg on receiving the @IASLC Early Career Award at WCLC! 👏🎉

A well-deserved recognition of her outstanding work and dedication to lung cancer research. Proud to share this journey with you!